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In the EU, the use as ingredients in food of several
major allergens or products derived thereof is to be
labelled according to EU Directives 2003/89/EC and
2006/142/EC. This obligation only concerns the use of
allergenic ingredients according to recipe. However,
allergens may also be present in food due to cross con-
tamination in food production facilities or contamina-
tion of raw materials or ingredients. Pele et al. (2007),
VWA (2007) and Spanjersberg et al. (2010) have
demonstrated the presence of considerable amounts of
allergens in many food products that did not carry any
w a r n i n gf o rt h ep r e s e n c eo ft h e s ea l l e r g e n s .T h ep r e -
sence of allergens without accompanying warning
obviously poses a risk to allergic consumers, as these
individuals have no opportunity to judge the appropri-
ateness of the concerning food products for them to eat
(Spanjersberg et al. 2010, Sheth 2010).
In contrast to the absence of any warning on many
products that do contain certain allergens, there appear
to be many food products in the market that carry a
precautionary (often called “may contain”) labelling to
warn consumers for the possibility of unintended pre-
sence of allergens. In many cases, such precautionary
labelling seems not to be based on a relevant risk but is
meant as a disclaimer in case the producer cannot
exclude a risk for 100%. This seems to lead to a non-
selective use of this precautionary labelling, which
causes other problems, such as a reduced food choice
for allergic consumers and devaluation of the informa-
tion value of such warning (Health Council of the Neth-
erlands 2007). The consequence of the dilemma’s
described above is that there are many products in the
market with a warning while there is no or only a very
small (negligible) risk and that, at the same time, there
are many products without a warning that contain
(sometimes very high amounts of) allergens. Precaution-
ary labelling seems to provide the allergic consumers
with no useful information anymore. Risk analysis prin-
ciples can be applied to solve this problem and to bring
guidance, harmonisation and transparency in informa-
tion delivery regarding possible unintended presence of
allergens in food products. For practical application of a
risk analysis-based approach, a risk assessment metho-
dology is essential.
We developed a risk assessment method to quantify
the number of allergic consumers that may suffer aller-
gic reactions to specific levels allergens in food products
or to calculate concentration action levels that can be
based on predefined tolerable risks (Spanjersberg et al.
2007 and 2010, Kruizinga 2008). Clinical threshold data
are of major importance in this methodology. Clinical
threshold data are available for most major food aller-
gens for which management of cross contamination
risks is needed. Suitability for use in risk assessment will
be discussed and it will be demonstrated how such clini-
cal thresholds can be used in allergen risk assessment
and risk management.
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